SE425739B - Forfarande for framstellning av vissa angivna tetrazolyl-bensopyranopyridinderivat - Google Patents

Forfarande for framstellning av vissa angivna tetrazolyl-bensopyranopyridinderivat

Info

Publication number
SE425739B
SE425739B SE7506058A SE7506058A SE425739B SE 425739 B SE425739 B SE 425739B SE 7506058 A SE7506058 A SE 7506058A SE 7506058 A SE7506058 A SE 7506058A SE 425739 B SE425739 B SE 425739B
Authority
SE
Sweden
Prior art keywords
benzopyranopyridine
tetrazolyl
derivatives
procedure
preparing certain
Prior art date
Application number
SE7506058A
Other languages
English (en)
Swedish (sv)
Other versions
SE7506058L (sv
Inventor
T Oe
M Tsuruda
Original Assignee
Yoshitomi Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical filed Critical Yoshitomi Pharmaceutical
Publication of SE7506058L publication Critical patent/SE7506058L/xx
Publication of SE425739B publication Critical patent/SE425739B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SE7506058A 1974-05-28 1975-05-27 Forfarande for framstellning av vissa angivna tetrazolyl-bensopyranopyridinderivat SE425739B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6063274A JPS5516432B2 (it) 1974-05-28 1974-05-28

Publications (2)

Publication Number Publication Date
SE7506058L SE7506058L (sv) 1975-12-01
SE425739B true SE425739B (sv) 1982-11-01

Family

ID=13147870

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7506058A SE425739B (sv) 1974-05-28 1975-05-27 Forfarande for framstellning av vissa angivna tetrazolyl-bensopyranopyridinderivat

Country Status (12)

Country Link
US (1) US4085111A (it)
JP (1) JPS5516432B2 (it)
AT (1) AT347946B (it)
BE (2) BE829474A (it)
CA (1) CA1046064A (it)
CH (1) CH605960A5 (it)
DE (1) DE2521980C2 (it)
FR (1) FR2279398A1 (it)
GB (1) GB1466493A (it)
NL (1) NL181408C (it)
SE (1) SE425739B (it)
ZA (1) ZA753091B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52105197A (en) * 1976-03-01 1977-09-03 Yoshitomi Pharmaceut Ind Ltd 1h-terazole derivatives
JPS5825677B2 (ja) * 1977-09-26 1983-05-28 武田薬品工業株式会社 3−テトラゾ−ル−1−アザキサントン誘導体およびその製造法
JPS56100719A (en) * 1980-01-17 1981-08-12 Yoshitomi Pharmaceut Ind Ltd Antirheumatic agent
US4555510A (en) * 1982-10-30 1985-11-26 Yoshitomi Pharmaceutical Industries, Ltd. Therapeutic agent for hypertension
FR2549831A1 (fr) * 1983-07-27 1985-02-01 Rhone Poulenc Agrochimie Nouveaux derives d'acides aryloxybenzoiques, et leur utilisation comme herbicides
WO2003090699A1 (fr) * 2002-04-23 2003-11-06 L'oreal Composition cosmetique pour favoriser la pousse et/ou empecher ou retarder la chute des cheveux
FR2838641B1 (fr) * 2002-04-23 2005-12-23 Oreal Composition cosmetique, procede de traitement cosmetique et preparation d'une composition pour favoriser la pousse et/ou empecher ou retarder la chute des cheveux
US7320967B2 (en) * 2002-04-23 2008-01-22 L'oreal Cosmetic composition, method of cosmetic treatment and preparation of a composition for promoting the growth and/or preventing or delaying the loss of hair
PT3013813T (pt) 2013-06-27 2019-06-14 Pfizer Compostos heteroaromáticos e a sua utilização como ligandos de d1 de dopamina

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2977372A (en) * 1958-04-09 1961-03-28 William G Finnegan Process for preparing substituted tetrazoles
US3536715A (en) * 1967-03-24 1970-10-27 Miles Lab 2-lower alkyl-5-(omega-(4-phenyl-1-piperazinyl) lower alkyl)-2h-tetrazoles
GB1362782A (en) * 1970-08-26 1974-08-07 Fisons Ltd Tetrazole derivatives
BE759292A (fr) * 1969-11-27 1971-05-24 Allen & Hanburys Ltd Derives de xanthone, leur preparation et leur emploi
GB1403487A (en) * 1972-07-21 1975-08-28 Yoshitomi Pharmaceutical Heterocyclic substituted alkanoic acids and derivatives
US3939173A (en) * 1972-09-06 1976-02-17 Burroughs Wellcome Co. Substituted carbonyl compounds
NL7403583A (it) * 1973-03-19 1974-09-23

Also Published As

Publication number Publication date
US4085111A (en) 1978-04-18
SE7506058L (sv) 1975-12-01
FR2279398B1 (it) 1980-02-15
JPS50151897A (it) 1975-12-06
DE2521980C2 (de) 1985-08-22
ZA753091B (en) 1976-04-28
GB1466493A (en) 1977-03-09
ATA402475A (de) 1978-06-15
BE888694Q (fr) 1981-08-28
DE2521980A1 (de) 1975-12-18
NL181408C (nl) 1987-08-17
CA1046064A (en) 1979-01-09
BE829474A (fr) 1975-09-15
AT347946B (de) 1979-01-25
JPS5516432B2 (it) 1980-05-01
NL181408B (nl) 1987-03-16
FR2279398A1 (fr) 1976-02-20
NL7506210A (nl) 1975-12-02
CH605960A5 (it) 1978-10-13
AU8149875A (en) 1976-11-25

Similar Documents

Publication Publication Date Title
SE428562B (sv) Forfarande for framstellning av purinderivat
SE423633B (sv) Forfarande for framstellning av 4-demetoxi-daunomycin
SE420199B (sv) Forfarande for framstellning av 16-oxiderade prostansyraderivat
SE431652B (sv) Forfarande for framstellning av 7beta-amino-3cefem-3ol-4-karboxylsyraderivat
SE412066B (sv) Forfarande for framstellning av famakologiskt verksamma tienodiazinderivat
SE431211B (sv) Forfarande for framstellning av n-acylamino-alfa-arylacetamido-cefalosporiner
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE7508074L (sv) Forfarande for framstellning av stilbenderivat.
SE421612B (sv) Forfarande for framstellning av alfa-6-deoxi-5-hydroxitetracyklin
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
SE422052B (sv) Forfarande for framstellning av vissa angivna 1-fenoxi-2-hydroxi-3-aminofenyl-propylderivat
SE418292B (sv) Forfarande for framstellning av 5-aryl-2-furamidiner
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE425739B (sv) Forfarande for framstellning av vissa angivna tetrazolyl-bensopyranopyridinderivat
SE400960B (sv) Forfarande for framstellning av alhŸ3 (poŸ4)Ÿ2 3hŸ2o
SE414926B (sv) Forfarande for framstellning av 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler
SE422202B (sv) Forfarande for framstellning av amidoximderivat
SE419543B (sv) Forfarande for framstellning av vissa angivna isokinolinderivat
SE422210B (sv) Analogiforfarande for framstellning av substituerade indoler
SE415658B (sv) Analogiforfarande for framstellning av linnolinderivat
SE404364B (sv) Forfarande for framstellning av vissa angivna 5-sulfonylfenyl-tetrazolderivat
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE425784B (sv) Analogiforfarande for framstellning av eburnameninderivat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7506058-2

Effective date: 19910123

Format of ref document f/p: F